Texaf SA
XBRU:TEXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Texaf SA
XBRU:TEXF
|
BE |
|
R
|
Resmed Inc
ASX:RMD
|
US |
|
C
|
Clinuvel Pharmaceuticals Ltd
XMUN:UR9
|
AU |
|
West High Yield (WHY) Resources Ltd
XTSX:WHY
|
CA |
|
Societe Francaise de Casinos SA
PAR:SFCA
|
FR |
|
Hansard Global PLC
F:H9G
|
IM |
|
I
|
Itron Inc
DUS:IT6
|
US |
|
WildBrain Ltd
TSX:WILD
|
CA |
|
C
|
Chugai Pharmaceutical Co Ltd
DUS:CUP
|
JP |
Intrinsic Value
Is TEXF undervalued or overvalued?
See the intrinsic value estimate for Texaf SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
TEXF looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with TEXF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Texaf Does
Texaf SA is a Belgian-listed company with most of its business tied to the Democratic Republic of Congo, especially Kinshasa. It builds, owns, and rents real estate such as offices, homes, and mixed-use sites, and it also runs a quarry business that supplies stone and construction materials. In addition, it has digital and infrastructure assets that support local businesses, including data and connectivity services.
- Headquarters
- Belgium BE
- IPO date
- Dec 12, 2012
Earnings Waterfall
Texaf SA
The intrinsic value for Texaf SA (TEXF) under the Base Case is hidden EUR.
Compared with the current market price of 35 EUR, the stock appears hidden.